Verzenio 50 mg (Abemaciclib TABLET) 50 MG

VERZENIO 50 MG tablets contain abemaciclib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Eli Lilly Canada Inc. and is available in a 50 MG strength.

Strength

50 MG

Manufacturer / TM Owner

ELI LILLY CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VERZENIO 50 MG tablets are typically used in the treatment of advanced or metastatic breast cancer. Abemaciclib is often prescribed in combination with other therapies to help manage cancer growth. Patients may wonder, 'What is VERZENIO used for?' This medication is specifically designed to target and inhibit cancer cell proliferation.

Side Effects

Common effects of VERZENIO 50 MG tablets may include fatigue, nausea, and diarrhea. Some users might experience a decrease in appetite or hair loss. It's important to note that individual responses to abemaciclib can vary, and not everyone will experience these effects.

Precautions & Warnings

VERZENIO 50 MG tablets should be handled with care and stored as directed. Patients should follow their healthcare provider's instructions for administration. It's crucial to inform your healthcare provider about any pre-existing conditions or allergies before starting this medication.

Avoid Interactions

VERZENIO 50 MG tablets may interact with certain medications, including those that are metabolized by the liver. Alcohol and other substances that affect liver enzymes could potentially alter the effectiveness of abemaciclib. Always consult with a healthcare provider before combining VERZENIO with other treatments.

Frequently Asked Questions

VERZENIO is used in the treatment of advanced or metastatic breast cancer, often in combination with other therapies.

VERZENIO tablets are taken orally, typically as directed by a healthcare provider. Always follow the prescribed dosage and administration instructions.

Common side effects may include fatigue, nausea, diarrhea, and hair loss. Individual experiences can vary.

VERZENIO may interact with certain medications, so it's important to consult with a healthcare provider before combining it with other treatments.

VERZENIO is manufactured by Eli Lilly Canada Inc. in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.